← Back to Search

Behavioral Intervention

Peer Support for Bone Marrow Transplant Recipients

N/A
Recruiting
Led By Samantha Mayo, RN PhD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
More than 3 months post Allo-HSCT
Any malignant/non-malignant indication for Allo-HSCT
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months, and 6 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to see if a peer support program for young adults undergoing stem cell transplant is helpful. The study will look at whether this program can improve mental health outcomes such as happiness, self-esteem,

Who is the study for?
This trial is for adolescents and young adults who are undergoing allogeneic stem cell transplants, a treatment often used for serious blood disorders including cancer. Participants should be interested in joining a peer support group to potentially improve their mental health during the transplant process.
What is being tested?
The study is testing the effectiveness of a peer support program designed specifically for young patients receiving stem cell transplants. The goal is to see if this social support can help reduce feelings of loneliness, anxiety, and depression while increasing happiness and self-esteem.
What are the potential side effects?
Since this trial involves peer support rather than medication or medical procedures, there aren't typical side effects. However, participants may experience varying emotional responses to sharing experiences with peers.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
It has been over 3 months since my stem cell transplant.
Select...
I am a candidate for a stem cell transplant from a donor.
Select...
I am between 18 and 39 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months, and 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acceptability of Intervention Measure (AIM)
Feasibility of Intervention Measure (FIM)
Intervention Appropriateness Measure (IAM)
+2 more
Secondary study objectives
Anxiety
Depressive Symptoms
Social Connectedness

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Peer SupportExperimental Treatment1 Intervention
The intervention will be a monthly online AYA peer support group (1 hour) that will run for six months via Microsoft Teams.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Peer Support
2011
N/A
~6610

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,531 Previous Clinical Trials
504,307 Total Patients Enrolled
33 Trials studying Leukemia
9,437 Patients Enrolled for Leukemia
Samantha Mayo, RN PhDPrincipal InvestigatorUniversity Health Network, Toronto
~2 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top